← Back to Analyst Consensus 
BNTX Buy
BioNTech SE
Current Price —
Implied Upside —
Analysts 28
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 14, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Oct 7, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Sep 8, 2026 | BMO Capital | downgrade | Outperform → Market Perform | — | 53% |
| Aug 31, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Aug 5, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Aug 5, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Jul 8, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| May 27, 2026 | UBS | upgrade | Neutral → Buy | — | 54% |
| May 22, 2026 | Bernstein | initiate | — → Market Perform | — | 52% |
| May 6, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 6, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Apr 27, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 10, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Mar 31, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 11, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Mar 11, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Mar 11, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 11, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| Mar 11, 2026 | BMO Capital | maintain | Outperform → Outperform | — | 53% |
| Mar 10, 2026 | Jefferies | maintain | Buy → Buy | — | 52% |
| Jan 16, 2026 | Goldman Sachs | upgrade | Neutral → Buy | $142 | 54% |
| Nov 10, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $140 | 44% |
| Nov 6, 2025 | UBS | maintain | Neutral → Neutral | $117 | 54% |
| Oct 23, 2025 | JP Morgan | maintain | Neutral → Neutral | $120 | 54% |
| Oct 10, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $131 | 54% |
| Sep 22, 2025 | JP Morgan | maintain | Neutral → Neutral | $121 | 54% |
| Sep 8, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $136 | 44% |
| Aug 14, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $136 | 44% |
| Aug 5, 2025 | Wells Fargo | maintain | Overweight → Overweight | $150 | 54% |
| Aug 5, 2025 | B of A Securities | maintain | Buy → Buy | $134 | 53% |
| Jul 16, 2025 | B of A Securities | maintain | Buy → Buy | $126 | 53% |
| Jul 10, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $133 | 54% |
| Jun 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $138 | 44% |
| Jun 16, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $138 | 44% |
| Jun 5, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $145 | 44% |
| Jun 3, 2025 | Truist Securities | reiterate | Buy → Buy | $155 | 54% |
| May 29, 2025 | Goldman Sachs | initiate | — → Neutral | $110 | 54% |
| May 22, 2025 | JP Morgan | maintain | Neutral → Neutral | $116 | 54% |
| May 22, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $134 | 44% |
| May 14, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $134 | 44% |
| May 6, 2025 | Citigroup | maintain | Buy → Buy | $140 | 54% |
| May 6, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $132 | 54% |
| Apr 1, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $145 | 44% |
| Mar 13, 2025 | Citigroup | initiate | — → Buy | $145 | 54% |
| Mar 11, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $139 | 54% |
| Mar 11, 2025 | Canaccord Genuity | maintain | Buy → Buy | $171.44 | 48% |
| Mar 11, 2025 | BMO Capital | maintain | Outperform → Outperform | $143 | 53% |
| Mar 11, 2025 | Truist Securities | maintain | Buy → Buy | $151 | 54% |
| Jan 27, 2025 | JP Morgan | maintain | Neutral → Neutral | $120 | 54% |
| Jan 10, 2025 | Truist Securities | initiate | — → Buy | $172 | 54% |
Price Target Trend
Jul 23, 2026 Oct 26, 2026
EPS Estimates
+1y —
0y —
0q —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days